132
Participants
Start Date
March 31, 2015
Primary Completion Date
March 31, 2019
Study Completion Date
June 30, 2019
Trastuzumab
"\- Eight times IV administration of trastuzumab per 3 weeks~* Trastuzumab 8mg/kg on Day 1 of Cycle 1~* Trastuzumab 6mg/kg from Day 1 of Cycle 2 to Day 1 of Cycle 8"
Letrozole
\- Daily letrozole 2.5 mg/day for 24 weeks
RECRUITING
Gangnam Severance Hospital, Seoul
RECRUITING
Hallym University Sacred Heart Hospital, Anyang
NOT_YET_RECRUITING
Inje University Pusan Paik Hospital, Busan
RECRUITING
Dankook University Hospital, Cheonan
RECRUITING
Ilsan Paik Hospital, Goyang
NOT_YET_RECRUITING
National Cancer Center, Goyang
NOT_YET_RECRUITING
Asan Medical Center, Seoul
RECRUITING
Kangbuk Samsung Hospital, Seoul
RECRUITING
Korea Institute of Radiological and Medical Sciences, Seoul
RECRUITING
Korea University Anam Hospital, Seoul
NOT_YET_RECRUITING
Samsung Medical Center, Seoul
RECRUITING
Seoul Medical Center, Seoul
RECRUITING
Seoul National University Hospital, Seoul
NOT_YET_RECRUITING
Ajou University School of Medicine, Suwon
Collaborators (1)
Seoul National University Hospital
OTHER
Severance Hospital
OTHER
Samsung Medical Center
OTHER
Asan Medical Center
OTHER
Gangnam Severance Hospital
OTHER